HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis

IntroductionThe immunological drivers of portal hypertension regression after hepatitis C virus (HCV) cure are poorly understood, particularly in the context of human immunodeficiency virus (HIV) coinfection We aimed to identify baseline immune signatures predicting the evolution of the hepatic veno...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rubén Martín-Escolano, Amanda Fernández-Rodríguez, Laura Tarancon-Diez, Juan Berenguer, Helena Codina, Rafael Amigot-Sánchez, Juan González-García, Víctor Hontañón, Leire Pérez-Latorre, Luis Ibañez-Samaniego, Elba Llop-Herrera, Antonio Olveira, Laura Díaz, Isidoro Martínez, María Ángeles Jiménez-Sousa, Salvador Resino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-02-01
coleção:	Frontiers in Immunology
Assuntos:	biomarkers chronic hepatitis C DAA therapy HIV HVPG regression immunological profile
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1683092/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!